| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.083 | 0.009 |